Anavex Life Sciences Corp (AVXL)

[Gator328]

$2.68 needs to hold over the next week, if it does I think we can say goodbye to the $2.2s forever.

Still an all or none gamble because AVXL doesn't have any other revenue producing assets. But relative to other ALZ pipeline drugs, 273 has as good a shot as any and AVXL seems cheap relative to other similar stage bio startups.

It wouldn't surprise me to see $4-$5 by July.